Marvel Biosciences Closes Private Placement

Calgary, Alberta, Canada, July 19, 2024 – Marvel Biosciences Corp. (TSX-V: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), is pleased to report that, further to its press releases of May 16, 2024 and...

Marvel Biosciences Corp. Announces Private Placement

Calgary, Alberta, Canada, May 16, 2024 – Marvel Biosciences Corp. (TSX-V: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), is pleased to announce a proposed non-brokered private placement of up to...